Treatment | Growth | Strategy
LIVE ONLINE 20 May 2021
Bio Integrates Speakers 2021
DR ANDY RICHARDS CBE
Entrepreneur and Investor
IAN MCCUBBIN OBE
Leader of Manufacturing
Vaccines Task Force
ELIOT FORSTER
Chief Executive Officer
F-star
JANE DANCER
Independent Consultant
MARTINO PICARDO
Chairman
Discovery Park
SUZANNE DILLY
Chief Executive Officer
ValiRx PLC
MATTHEW DURDY
Chief Executive Officer
Cell and Gene Therapy Catapult
CHRISTIAN JONES
Chief Commercial Officer
Nanoform
KEVIN COX
Chair
Biorelate
IAN CAMPBELL
Chief Business Officer
LifeArc
JAMES FRY
Partner and Head of Life Sciences
Mills & Reeve
IAN MUIR
Chief Executive Officer
Porton Biopharma
SHADI FARHANGRAZI
Chief Executive Officer
S. M. Discovery Group
JONATHAN APPLEBY
Chief Scientific Officer
Cell and Gene Therapy Catapult
PATRICK DRISCOLL
Chief Financial Officer
CN Bio Innovations
HANNAH WADE
Head of Investor Partnerships
CPI
CLARE TERLOUW
Head of Ventures
LifeArc
JESÚS ZURDO
Global Head Cell, Gene Therapy & Bioproduction
Horizon Discovery
MEL WALKER
Managing Director
BioPharma Futures
TOBY REID
Chief Executive Officer
BioCity Group
WILL BROOKS
Investment Director
Downing
EUAN CAMERON
Chief Executive Officer & Founder
COHESION Medical
ZAHID MONEER
Head of Healthcare, Investment Banking Division
BNP Paribas
VICKY STEADMAN
Senior Director, Business Development
Sai Life Sciences
PRIYA MANDE
Chief Operating Officer
PsiOxus Therapeutics
AJAY MISTRY
Co-Founder & Chief Executive Officer
Oppilotech
EMMANUEL LIGNER
President and Chief Executive Officer
Cytiva
KATH MACKAY
Managing Director
Bruntwood SciTech – Alderley Park
MAIREADH PEDERSEN
Chief Executive Officer
QuayPharma
DAVID PORTER
Founding Partner
Apposite Capital
MARTIN-IMMANUEL BITTER
Chief Executive Officer
Arctoris
REBECCA TODD
Investment Director
Longwall Venture Partners
NATALIA NOVAC
Senior Director, Emerging Technology & Innovation, Corporate Business Development
Eli Lilly
RICHARD WEAVER
Senior Vice President – Pre-Clinical Development
Sygnature Discovery
BRUCE CLARK
Past President and Chief Executive Officer
Medicago Inc.
CLAIRE BROWN
Investment Director
BioCity
DOUG DANISON
Head of Europe
Bluebird Bio
CAROLE LONGSON
Independent Senior Adviser, Life Science Policy, HTA and Market Access and Vice Chair
Medicines Discovery Catapult
TOM MANDER
Chief Operating Officer
Domainex
RICHARD WILLIAMS
SVP CMC and Development
Crescendo Biologics
TIM LUKER
Vice President Emerging Technology and Innovation
ELI LILLY
JAMES ZHANG
Co-Founder and Chief Executive Officer
Phoenix DX
MIKE FRODSHAM
Chief Technical Officer
QuayPharma
NATHALIE HUTHER
Senior Director of Business Development, Europe
Arcinova – A Quotient Sciences business
PETER LYFORD
Business Development Director
Porton Pharma Solutions
ROISIN NICAMHLAOIBH
Head of Partnerships and Business Development
Rosalind Franklin Institute
PAUL STOTT
Chief Executive Officer
Seda Pharmaceutical Development Services
KATHRYN SIMPSON
Business Consultant
Kathryn Simpson Consulting
JOANNA GOULD
Chief Executive Officer and Co-Founder
VisusNano
JENNY LAIRD
Vice President, Search & Evaluation Pain & Neurodegeneration
Eli Lilly
EDDIE BLAIR
Chairman
Virokine Therapeutics
CHARLOTTE CASEBOURNE
Co-Founder & Chief Executive Officer
Theolytic
STEPHEN TOOKER
Vice President, Commercial Packaging – Europe
PCI Pharma Services
JOE DE SOUSA
Senior Leader, Non-Exec Director and Independent Consultant
Melhor Consulting
JASON MELLAD
Chief Executive Officer
Start Codon
STEVE McCONCHIE
Chief Executive Officer
Aptus Clinical
MATTHEW DUCHARS
Chief Executive Officer
VMIC UK
JILL RECKLESS
Chief Executive Officer
RxCelerate
ADRIAN HILL
HealthTec Development Manager
UKRI – STFC, Harwell Campus
DAVID ATKINS
Chief Executive Officer
Congenica
AMIT SHAH
Biotech Venture Capital Investor
S.R. One Ltd
HENRI LOUW
HR Director
AbbVie
CATHERINE PICKERING
Chief Executive Officer and Co-founder
iOnctura SA
JOHN COLEMAN
Head of Quality and Business Development
Your Special Delivery Service
PATRICIA FURLONG
Founding President and Chief Executive Officer
Parent Project Muscular Dystrophy (PPMD)
FLIC GABBAY
Managing Partner
tranScrip
EMMA PALMER FOSTER
Strategic Communications Consultant
The Oxford Science Park
TIM HAINES
Chairman and Managing Partner
Abingworth LLP
DAVID BEADLE
Non-Executive Director
Phico Therapeutics
WILLS HUGHES-WILSON
Chief Patient Access & Commercial Planning
Mereo Biopharma
JASON FOSTER
Chief Executive Officer and Executive Director
Ori Biotech
JOLYON MARTIN
Founder and Business Development
PetMedix
LUCY FOLEY
Director of Biologics
CPI
GRAHAM BOND
Managing Partner
RSM UK Audit LLP
SONIA HOUGHTON
Chief Executive Officer & Co-Founder
Cryoniss
FRAN CRAWFORD
Chief Executive Officer
Somaserve
DEBORA LUCARELLI
Chief Executive Officer
Enhanc3D Genomics
GREG BROOKE
Senior Lecturer in Molecular and Cellular Biology
University of Essex
JOHN VANDORE
Business Development
Harwell Campus
NEIL JONES
Chief Business Officer
VMIC UK
MAYER SCHREIBER
Chief Executive Officer
Discovery Park
HAKAN GOKER
Vice President
M Ventures
RICHARD HEBDON
Head of Health & Medicine, Ageing Society, Health & Nutrition Sector
Innovate UK
ELEANOR DAVIES
Managing Partner
The RSA Group
SANDY DOUGLAS
Research Group Leader
The University of Oxford
RORY MAW
Director
The Oxford Science Park
ANDREW FADDEN
Vice President and Head of Corporate Development
Enara Bio
HELEN BARKER
Head of Pharmaceutical Development
Reneo Pharma
JEROEN VERHEYEN
Co-Founder and Chief Executive Officer
Semarion
PHIL L’HUILLER
Chief Executive Officer
CatalYm
JOHN POTTAGE
Former Senior Vice President, Chief Scientific and Medical Officer
ViiV Healthcare
ALEX HAMILTON
Partner
Syncona Investment Management
IAN MCKAY
Innovation Lead for Advanced Therapies
InnovateUK
KARIN SCHMITT
Chief Business Officer
Mogrify
TOBY PETERS
Professor in Cold Economy and Co-Director
University of Birmingham and Centre for Sustainable Cooling
NICK SMITH
Associate Director of Operations
Cobra Biologics
NEIL TORBETT
Chief Operating Officer
PhoreMost
EDWIN DYSON
Managing Director
Cryo Storage Solutions
Valued silver sponsors
Treatment | Growth | Strategy
LIVE ONLINE 20 May 2021